Cigarette smoking remains the most preventable cause of illness, death and excess healthcare costs in the UK. Most smokers want to stop smoking and intend to stop at some point. In this fourth article in our occasional series on smoking cessation in primary care, we look at the evidence for the use of antidepressants, including bupropion, which is licensed for this indication, and nortriptyline, which is not
Background Smoking is a main cause of early death throughout the world. There are a number of medi...
Background: Studies undertaken in academic settings have shown that bupropion hydrochloride can doub...
ABSTRACT While the proportion of the adult population that smokes has declined steadily in several ...
Cigarette smoking remains the most preventable cause of illness, death and excess healthcare costs i...
This article reviews the efficacy of nortriptyline for smoking cessation based on a meta-analysis of...
Background: The observations that smokers with chronic obstructive pulmonary disease (COPD) are at i...
Bupropion SR is approved for the treatment of tobacco dependence in adult smokers. Bupropion SR is a...
Background: Smoking cessation is the single most effective way of preventing progression of chronic ...
OBJECTIVES: In healthy smokers, antidepressants can double the odds of cessation. Because of its fou...
OBJECTIVES: The objective of this paper is to evaluate the efficacy of nortriptyline for smoking ces...
The advent of bupropion hydrochloride sustained release (Zyban) has heralded a major change in the o...
Background: Whilst the pharmacological profiles and mechanisms of antidepressants are varied, there ...
Background: Effective pharmacotherapies are available for smoking cessation but their efficacy is es...
Tobacco use disorder is a chronic illness. With its high comorbidity rate, it is a major cause of ye...
SummaryInternational chronic obstructive pulmonary disease guidelines recommend that smokers be stro...
Background Smoking is a main cause of early death throughout the world. There are a number of medi...
Background: Studies undertaken in academic settings have shown that bupropion hydrochloride can doub...
ABSTRACT While the proportion of the adult population that smokes has declined steadily in several ...
Cigarette smoking remains the most preventable cause of illness, death and excess healthcare costs i...
This article reviews the efficacy of nortriptyline for smoking cessation based on a meta-analysis of...
Background: The observations that smokers with chronic obstructive pulmonary disease (COPD) are at i...
Bupropion SR is approved for the treatment of tobacco dependence in adult smokers. Bupropion SR is a...
Background: Smoking cessation is the single most effective way of preventing progression of chronic ...
OBJECTIVES: In healthy smokers, antidepressants can double the odds of cessation. Because of its fou...
OBJECTIVES: The objective of this paper is to evaluate the efficacy of nortriptyline for smoking ces...
The advent of bupropion hydrochloride sustained release (Zyban) has heralded a major change in the o...
Background: Whilst the pharmacological profiles and mechanisms of antidepressants are varied, there ...
Background: Effective pharmacotherapies are available for smoking cessation but their efficacy is es...
Tobacco use disorder is a chronic illness. With its high comorbidity rate, it is a major cause of ye...
SummaryInternational chronic obstructive pulmonary disease guidelines recommend that smokers be stro...
Background Smoking is a main cause of early death throughout the world. There are a number of medi...
Background: Studies undertaken in academic settings have shown that bupropion hydrochloride can doub...
ABSTRACT While the proportion of the adult population that smokes has declined steadily in several ...